GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LabTurbo Biotech Corp (ROCO:7725) » Definitions » Loans Receivable

LabTurbo Biotech (ROCO:7725) Loans Receivable : NT$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LabTurbo Biotech Loans Receivable?

LabTurbo Biotech's Loans Receivable for the quarter that ended in Jun. 2024 was NT$0.00 Mil.


LabTurbo Biotech Loans Receivable Historical Data

The historical data trend for LabTurbo Biotech's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabTurbo Biotech Loans Receivable Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23
Loans Receivable
- - -

LabTurbo Biotech Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Loans Receivable Get a 7-Day Free Trial - - - - -

LabTurbo Biotech Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


LabTurbo Biotech Loans Receivable Related Terms

Thank you for viewing the detailed overview of LabTurbo Biotech's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


LabTurbo Biotech Business Description

Traded in Other Exchanges
N/A
Address
3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.

LabTurbo Biotech Headlines

No Headlines